ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 683,80
0,30%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Biodesix Inc (BDSX)

  7. Biodesix Inc (BDSX) Actualités

BDSX Biodesix Inc

1,43
0,08 (5,93%)
31 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Biodesix Inc BDSX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,08 5,93% 1,43 23:24:56
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,35 1,3431 1,46 1,43 1,35
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
28/5/202412:00BWBiodesix to Participate in Two Investor Conferences in June
24/5/202422:11EDGAR2Form S-1/A - General form for registration of securities..
24/5/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:09EDGAR2Form SC 13D/A - General statement of acquisition of..
21/5/202412:00BWBiodesix to Present New Data on the Nodify XL2® Test at ATS..
10/5/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202422:07EDGAR2Form 144 - Report of proposed sale of securities
09/5/202422:06EDGAR2Form 144 - Report of proposed sale of securities
09/5/202422:06EDGAR2Form 144 - Report of proposed sale of securities
09/5/202422:04EDGAR2Form 144 - Report of proposed sale of securities
08/5/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:05EDGAR2Form 8-K - Current report
08/5/202422:01BWBiodesix Announces First Quarter 2024 Results Driven by..
07/5/202412:00BWBiodesix to Participate in the 2024 RBCCM Global Healthcare..
24/4/202412:00BWBiodesix to Report First Quarter 2024 Financial Results on..
09/4/202423:00BWBiodesix to Present New Data on Liquid Biopsy Technologies..
05/4/202413:17BWBiodesix Announces Pricing of Oversubscribed and Upsized..
25/3/202411:00BWBiodesix Announces New Master Collaborative Research..
01/3/202412:11EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/3/202412:05EDGAR2Form 8-K - Current report
01/3/202412:00BWBiodesix Announces Fourth Quarter and Fiscal Year 2023..
01/3/202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202412:00BWBiodesix to Participate in the TD Cowen 44th Annual Health..
16/2/202412:00BWBiodesix to Report Fourth Quarter and Full Year 2023..
13/2/202403:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202403:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202403:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202403:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202403:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202401:06EDGAR2Form 144 - Report of proposed sale of securities
10/2/202401:05EDGAR2Form 144 - Report of proposed sale of securities
10/2/202401:05EDGAR2Form 144 - Report of proposed sale of securities
10/2/202401:04EDGAR2Form 144 - Report of proposed sale of securities
02/2/202422:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/1/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
BDSX
Biodesix
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés